Trials / Sponsors / Jiangmen Central Hospital
Jiangmen Central Hospital
Academic / Other · 3 registered clinical trials — 1 currently recruiting.
| Status | Trial | Phase | Started |
|---|---|---|---|
| Not Yet Recruiting | Furmonertinib Plus Radiotherapy for EGFR+ NSCLC With Pleural Effusion Lung Cancer (NSCLC), Malignant Pleural Effusions (Mpe)- Pleurodesis | Phase 2 | 2026-03-01 |
| Unknown | Toripalimab Combined With Gemcitabine/5--fluoropyrimidine for Advanced Cholangiocarcinoma Advanced Cholangiocarcinoma | Phase 2 | 2019-07-13 |
| Unknown | The Safety and Effects of Gefitinib in Triple-negative,EGFR Positive Metastatic Breast Cancer Breast Cancer | Phase 2 | 2013-01-01 |